Cargando…

Evaluation of the rapid diagnostic test CareStart pLDH Malaria (Pf-pLDH/pan-pLDH) for the diagnosis of malaria in a reference setting

BACKGROUND: The present study evaluated CareStart pLDH Malaria, a three-band rapid diagnostic test detecting Plasmodium falciparum-specific parasite lactate dehydrogenase (Pf-pLDH) and pan Plasmodium-specific pLDH (pan-pLDH) in a reference setting. METHODS: CareStart pLDH was retrospectively and pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Heutmekers, Marloes, Gillet, Philippe, Maltha, Jessica, Scheirlinck, Annelies, Cnops, Lieselotte, Bottieau, Emmanuel, Van Esbroeck, Marjan, Jacobs, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464813/
https://www.ncbi.nlm.nih.gov/pubmed/22704733
http://dx.doi.org/10.1186/1475-2875-11-204
_version_ 1782245479224967168
author Heutmekers, Marloes
Gillet, Philippe
Maltha, Jessica
Scheirlinck, Annelies
Cnops, Lieselotte
Bottieau, Emmanuel
Van Esbroeck, Marjan
Jacobs, Jan
author_facet Heutmekers, Marloes
Gillet, Philippe
Maltha, Jessica
Scheirlinck, Annelies
Cnops, Lieselotte
Bottieau, Emmanuel
Van Esbroeck, Marjan
Jacobs, Jan
author_sort Heutmekers, Marloes
collection PubMed
description BACKGROUND: The present study evaluated CareStart pLDH Malaria, a three-band rapid diagnostic test detecting Plasmodium falciparum-specific parasite lactate dehydrogenase (Pf-pLDH) and pan Plasmodium-specific pLDH (pan-pLDH) in a reference setting. METHODS: CareStart pLDH was retrospectively and prospectively assessed with a panel of stored (n = 498) and fresh (n = 77) blood samples obtained in international travelers suspected of malaria. Both panels comprised all four Plasmodium species; the retrospective panel comprised also Plasmodium negative samples. The reference method was microscopy corrected by PCR. The prospective panel was run side-to-side with OptiMAL (Pf-pLDH/pan-pLDH) and SDFK60 (histidine-rich protein-2 (HRP-2)/pan-pLDH). RESULTS: In the retrospective evaluation, overall sensitivity for P. falciparum samples (n = 247) was 94.7%, reaching 98.7% for parasite densities > 1,000/μl. Most false negative results occurred among samples with pure gametocytaemia (2/12, 16.7%) and at parasite densities ≤ 100/μl (7/12, 58.3%). None of the Plasmodium negative samples (n = 96) showed visible test lines. Sensitivities for Plasmodium vivax (n = 70), Plasmodium ovale (n = 69) and Plasmodium malariae (n = 16) were 74.3%, 31.9% and 25.0% respectively. Wrong species identification occurred in 10 (2.5%) samples and was mainly due to P. vivax samples reacting with the Pf-pLDH test line. Overall, Pf-pLDH test lines showed higher line intensities compared to the pan-pLDH lines (67.9% and 23.0% medium and strong line intensities for P. falciparum). In the prospective panel (77 Plasmodium-positive samples), CareStart pLDH showed higher sensitivities for P. falciparum compared to OptiMAL (p = 0.008), lower sensitivities for P. falciparum as compare to SDFK60 (although not reaching statistical significance, p = 0.08) and higher sensitivities for P. ovale compared to both OptiMAL (p = 0.03) and SDFK60 (p = 0.01). Inter-observer and test reproducibility were good to excellent. CONCLUSION: CareStart pLDH performed excellent for the detection of P. falciparum, well for P. vivax, but poor for P. ovale and P. malariae.
format Online
Article
Text
id pubmed-3464813
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34648132012-10-06 Evaluation of the rapid diagnostic test CareStart pLDH Malaria (Pf-pLDH/pan-pLDH) for the diagnosis of malaria in a reference setting Heutmekers, Marloes Gillet, Philippe Maltha, Jessica Scheirlinck, Annelies Cnops, Lieselotte Bottieau, Emmanuel Van Esbroeck, Marjan Jacobs, Jan Malar J Research BACKGROUND: The present study evaluated CareStart pLDH Malaria, a three-band rapid diagnostic test detecting Plasmodium falciparum-specific parasite lactate dehydrogenase (Pf-pLDH) and pan Plasmodium-specific pLDH (pan-pLDH) in a reference setting. METHODS: CareStart pLDH was retrospectively and prospectively assessed with a panel of stored (n = 498) and fresh (n = 77) blood samples obtained in international travelers suspected of malaria. Both panels comprised all four Plasmodium species; the retrospective panel comprised also Plasmodium negative samples. The reference method was microscopy corrected by PCR. The prospective panel was run side-to-side with OptiMAL (Pf-pLDH/pan-pLDH) and SDFK60 (histidine-rich protein-2 (HRP-2)/pan-pLDH). RESULTS: In the retrospective evaluation, overall sensitivity for P. falciparum samples (n = 247) was 94.7%, reaching 98.7% for parasite densities > 1,000/μl. Most false negative results occurred among samples with pure gametocytaemia (2/12, 16.7%) and at parasite densities ≤ 100/μl (7/12, 58.3%). None of the Plasmodium negative samples (n = 96) showed visible test lines. Sensitivities for Plasmodium vivax (n = 70), Plasmodium ovale (n = 69) and Plasmodium malariae (n = 16) were 74.3%, 31.9% and 25.0% respectively. Wrong species identification occurred in 10 (2.5%) samples and was mainly due to P. vivax samples reacting with the Pf-pLDH test line. Overall, Pf-pLDH test lines showed higher line intensities compared to the pan-pLDH lines (67.9% and 23.0% medium and strong line intensities for P. falciparum). In the prospective panel (77 Plasmodium-positive samples), CareStart pLDH showed higher sensitivities for P. falciparum compared to OptiMAL (p = 0.008), lower sensitivities for P. falciparum as compare to SDFK60 (although not reaching statistical significance, p = 0.08) and higher sensitivities for P. ovale compared to both OptiMAL (p = 0.03) and SDFK60 (p = 0.01). Inter-observer and test reproducibility were good to excellent. CONCLUSION: CareStart pLDH performed excellent for the detection of P. falciparum, well for P. vivax, but poor for P. ovale and P. malariae. BioMed Central 2012-06-18 /pmc/articles/PMC3464813/ /pubmed/22704733 http://dx.doi.org/10.1186/1475-2875-11-204 Text en Copyright ©2012 Heutmekers et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Heutmekers, Marloes
Gillet, Philippe
Maltha, Jessica
Scheirlinck, Annelies
Cnops, Lieselotte
Bottieau, Emmanuel
Van Esbroeck, Marjan
Jacobs, Jan
Evaluation of the rapid diagnostic test CareStart pLDH Malaria (Pf-pLDH/pan-pLDH) for the diagnosis of malaria in a reference setting
title Evaluation of the rapid diagnostic test CareStart pLDH Malaria (Pf-pLDH/pan-pLDH) for the diagnosis of malaria in a reference setting
title_full Evaluation of the rapid diagnostic test CareStart pLDH Malaria (Pf-pLDH/pan-pLDH) for the diagnosis of malaria in a reference setting
title_fullStr Evaluation of the rapid diagnostic test CareStart pLDH Malaria (Pf-pLDH/pan-pLDH) for the diagnosis of malaria in a reference setting
title_full_unstemmed Evaluation of the rapid diagnostic test CareStart pLDH Malaria (Pf-pLDH/pan-pLDH) for the diagnosis of malaria in a reference setting
title_short Evaluation of the rapid diagnostic test CareStart pLDH Malaria (Pf-pLDH/pan-pLDH) for the diagnosis of malaria in a reference setting
title_sort evaluation of the rapid diagnostic test carestart pldh malaria (pf-pldh/pan-pldh) for the diagnosis of malaria in a reference setting
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464813/
https://www.ncbi.nlm.nih.gov/pubmed/22704733
http://dx.doi.org/10.1186/1475-2875-11-204
work_keys_str_mv AT heutmekersmarloes evaluationoftherapiddiagnostictestcarestartpldhmalariapfpldhpanpldhforthediagnosisofmalariainareferencesetting
AT gilletphilippe evaluationoftherapiddiagnostictestcarestartpldhmalariapfpldhpanpldhforthediagnosisofmalariainareferencesetting
AT malthajessica evaluationoftherapiddiagnostictestcarestartpldhmalariapfpldhpanpldhforthediagnosisofmalariainareferencesetting
AT scheirlinckannelies evaluationoftherapiddiagnostictestcarestartpldhmalariapfpldhpanpldhforthediagnosisofmalariainareferencesetting
AT cnopslieselotte evaluationoftherapiddiagnostictestcarestartpldhmalariapfpldhpanpldhforthediagnosisofmalariainareferencesetting
AT bottieauemmanuel evaluationoftherapiddiagnostictestcarestartpldhmalariapfpldhpanpldhforthediagnosisofmalariainareferencesetting
AT vanesbroeckmarjan evaluationoftherapiddiagnostictestcarestartpldhmalariapfpldhpanpldhforthediagnosisofmalariainareferencesetting
AT jacobsjan evaluationoftherapiddiagnostictestcarestartpldhmalariapfpldhpanpldhforthediagnosisofmalariainareferencesetting